PL1704234T3 - Wytwarzanie glukagonopodobnego peptydu 2 i analogów - Google Patents

Wytwarzanie glukagonopodobnego peptydu 2 i analogów

Info

Publication number
PL1704234T3
PL1704234T3 PL04821092T PL04821092T PL1704234T3 PL 1704234 T3 PL1704234 T3 PL 1704234T3 PL 04821092 T PL04821092 T PL 04821092T PL 04821092 T PL04821092 T PL 04821092T PL 1704234 T3 PL1704234 T3 PL 1704234T3
Authority
PL
Poland
Prior art keywords
peptide
analogs
glp
glucagon
production
Prior art date
Application number
PL04821092T
Other languages
English (en)
Inventor
Ken Sasaki
Vanessa Jane Williamson
Alberto De Araujo
Ewa Walczyk
Original Assignee
Nps Pharma Inc
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nps Pharma Inc, Nycomed Gmbh filed Critical Nps Pharma Inc
Publication of PL1704234T3 publication Critical patent/PL1704234T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04821092T 2003-11-21 2004-11-22 Wytwarzanie glukagonopodobnego peptydu 2 i analogów PL1704234T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52366703P 2003-11-21 2003-11-21
EP04821092A EP1704234B1 (en) 2003-11-21 2004-11-22 Production of glucagon like peptide 2 and analogs
PCT/IB2004/004439 WO2005067368A2 (en) 2003-11-21 2004-11-22 Production of glucagon like peptide 2 and analogs

Publications (1)

Publication Number Publication Date
PL1704234T3 true PL1704234T3 (pl) 2012-06-29

Family

ID=34794202

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04821092T PL1704234T3 (pl) 2003-11-21 2004-11-22 Wytwarzanie glukagonopodobnego peptydu 2 i analogów

Country Status (13)

Country Link
US (2) US7829307B2 (pl)
EP (1) EP1704234B1 (pl)
AT (1) ATE541932T1 (pl)
CA (1) CA2546319A1 (pl)
DK (1) DK1704234T3 (pl)
ES (1) ES2380765T3 (pl)
HR (1) HRP20120315T1 (pl)
ME (1) ME01366B (pl)
PL (1) PL1704234T3 (pl)
PT (1) PT1704234E (pl)
RS (1) RS52246B (pl)
SI (1) SI1704234T1 (pl)
WO (1) WO2005067368A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101895047B1 (ko) 2011-12-30 2018-09-06 한미사이언스 주식회사 면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체
TWI591177B (zh) 2016-10-27 2017-07-11 中化合成生技股份有限公司 一種胰高血糖素胜肽－２（ｇｌｐ－２）類似物的製備方法
AU2018238302A1 (en) 2017-03-20 2019-10-24 Lupin Limited Expression and large-scale production of peptides
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
JP2023526625A (ja) 2020-05-19 2023-06-22 キャリーオペ，インク． Ａｍｐｋアクチベーター
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336336A (en) * 1979-01-12 1982-06-22 President And Fellows Of Harvard College Fused gene and method of making and using same
AU545912B2 (en) 1980-03-10 1985-08-08 Cetus Corporation Cloned heterologous jive products in bacillies
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
NZ199722A (en) 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
GR75411B (pl) 1981-04-29 1984-07-16 Biogen Nv
US4551433A (en) * 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
CA1341116C (en) 1983-02-22 2000-10-17 Rae Lyn Burke Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein
US4876197A (en) * 1983-02-22 1989-10-24 Chiron Corporation Eukaryotic regulatable transcription
JPS59166086A (ja) 1983-03-09 1984-09-19 Teruhiko Beppu 新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法
US4588684A (en) * 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
EP0127839B1 (en) 1983-05-27 1992-07-15 THE TEXAS A&M UNIVERSITY SYSTEM Method for producing a recombinant baculovirus expression vector
US4689406A (en) * 1983-08-10 1987-08-25 Amgen Enhancement of microbial expression of polypeptides
JPS6054685A (ja) 1983-09-02 1985-03-29 Suntory Ltd 改良発現ベクタ−およびその利用
EP0136907A3 (en) 1983-10-03 1986-12-30 Genentech, Inc. A xenogeneic expression control system, a method of using it, expression vectors containing it, cells transformed thereby and heterologous proteins produced therefrom
ZA848495B (en) 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
DE3587759T2 (de) 1984-05-11 1994-07-07 Chiron Corp., Emeryville, Calif. Erhöhte Hefetranskription unter Verwendung einer Hybridkonstruktion der Promotorregion.
US4880734A (en) * 1984-05-11 1989-11-14 Chiron Corporation Eukaryotic regulatable transcription
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
US4745056A (en) * 1984-10-23 1988-05-17 Biotechnica International, Inc. Streptomyces secretion vector
US4837148A (en) * 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
US5679543A (en) * 1985-08-29 1997-10-21 Genencor International, Inc. DNA sequences, vectors and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
IL80529A0 (en) * 1985-11-14 1987-02-27 Daiichi Seiyaku Co Method of producing peptides
ZA877505B (en) * 1986-10-14 1989-05-30 Lilly Co Eli Process for transforming a human insulin precursor to human insulin
US5420242A (en) * 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
JPS63123383A (ja) 1986-11-11 1988-05-27 Mitsubishi Kasei Corp ハイブリツドプロモ−タ−、発現調節ｄｎａ配列および発現ベクタ−
US4873192A (en) * 1987-02-17 1989-10-10 The United States Of America As Represented By The Department Of Health And Human Services Process for site specific mutagenesis without phenotypic selection
US4870023A (en) * 1987-03-16 1989-09-26 American Biogenetic Sciences, Inc. Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
US5416007A (en) * 1987-03-20 1995-05-16 Creative Biomolecules, Inc. Enhanced proteolytic cleavage of recombinant fusion proteins
DE3888561T2 (de) 1987-03-23 1994-09-01 Zymogenetics Inc Hohe Proteinsyntheserate in Hefe.
US4929555A (en) * 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
US5595887A (en) * 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
JPH04108378A (ja) 1990-08-28 1992-04-09 Sumitomo Electric Ind Ltd ヒトパーフォリンと反応するモノクローナル抗体
FI103805B1 (fi) * 1990-09-05 1999-09-30 Hoechst Ag Menetelmä preproinsuliinien hydroloimiseksi
US5580751A (en) * 1990-09-14 1996-12-03 Carlsberg A/S Process for the preparation of C-terminally amidated peptides
EP0499990B1 (en) 1991-02-19 1996-05-15 Takeda Chemical Industries, Ltd. Method for producing cysteine-free peptides
GB9203803D0 (en) 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
US5629005A (en) * 1992-05-01 1997-05-13 British United Shoe Machinery Limited Absorbent material and a method of making same
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5352771A (en) * 1992-08-31 1994-10-04 Iowa State University Research Foundation Inc. Hydrolysis of peptide bonds using Pt (II) and Pd (II) complexes
US5393924A (en) * 1992-10-02 1995-02-28 Hoechst Celanese Corporation Method for the preparation of arylalkanolamineacylates
US5512459A (en) * 1993-07-20 1996-04-30 Bionebraska, Inc. Enzymatic method for modification or recombinant polypeptides
DK144093D0 (pl) 1993-12-23 1993-12-23 Novo Nordisk As
WO1996017941A2 (en) 1994-12-07 1996-06-13 Bionebraska, Inc. Production of c-terminal amidated peptides from recombinant protein constructs
ATE260979T1 (de) * 1994-12-09 2004-03-15 Novo Nordisk As Verfahren zur herstellung extrazellulärer proteine in bakterien
DE4445891A1 (de) * 1994-12-22 1996-06-27 Boehringer Mannheim Gmbh Rekombinante Proteinase aus Clostridium histolyticum und ihre Verwendung zur Isolierung von Zellen und Zellverbänden
US5789379A (en) * 1995-04-14 1998-08-04 Allelix Biopharmaceutical Inc. Glucagon-like peptide-2 analogs
US6184201B1 (en) * 1995-04-14 2001-02-06 Nps Allelix Corp. Intestinotrophic glucagon-like peptide-2 analogs
US5629205A (en) * 1995-05-19 1997-05-13 Allelix Biopharmaceuticals Inc. Promoters for gene expression
US5851810A (en) * 1995-06-05 1998-12-22 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Nucleic acid encoding rhodococcus phenylalanine dehydrogenase
US5747453A (en) * 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
US6376529B1 (en) * 1995-06-07 2002-04-23 Peng Cho Tang Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof
US5912229A (en) * 1996-03-01 1999-06-15 Novo Nordisk Als Use of a pharmaceutical composition comprising an appetite-suppressing peptide
ZA976353B (en) 1996-07-19 1998-02-03 Monsanto Co Deformylation of f-met peptides in bacterial expression
US6660758B1 (en) * 1996-12-13 2003-12-09 The Scripps Research Institute Epothilone analogs
ES2308800T3 (es) * 1997-01-08 2008-12-01 Invitrogen Corporation Metodos para la produccion de proteinas.
US5846774A (en) * 1997-03-21 1998-12-08 Bionebraska, Inc. Chlorella virus promoters
KR100627590B1 (ko) 1998-01-30 2006-09-25 다이이치 아스비오파마 가부시키가이샤 보조 펩타이드를 사용하는 펩타이드의 제조방법
KR100319529B1 (ko) 1998-06-09 2002-01-09 김일웅 펩타이드 항생물질의 대량 생산 방법 및 그에 유용한 유전자 구조물
WO2000006763A1 (en) 1998-07-31 2000-02-10 Pierce Chemical Company Fusion products containing insoluble proteinaceous tag
US6692908B1 (en) 1998-11-05 2004-02-17 Stanford University Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptor
US6461834B1 (en) * 1998-11-06 2002-10-08 Bionebraska, Inc. Clostripain catalyzed amidation of peptides
GB9930882D0 (en) 1999-12-30 2000-02-23 Nps Allelix Corp GLP-2 formulations
US20030077826A1 (en) 2001-02-02 2003-04-24 Lena Edelman Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
FR2827818B1 (fr) 2001-07-25 2003-10-24 Inergy Automotive Systems Man Systeme d'obturation pour tubulure de remplissage de reservoir a carburant et procede pour ouvrir cette tubulure
AU2003231862A1 (en) * 2002-05-24 2003-12-12 Restoragen, Inc. Methods and dna constructs for high yield production of polypeptides
DE60334912D1 (de) 2002-05-24 2010-12-23 Medtronic Inc Polypeptid-spaltungsprozess
EP1572720A4 (en) * 2002-05-24 2008-12-24 Nps Allelix Corp PROCESS FOR THE ENZYMATIC PRODUCTION OF GLP-2 (1-34) AND GLP-2 (1-33) PEPTIDES
DK1532261T3 (da) * 2002-05-24 2010-05-31 Medtronic Inc Fremgangsmåder og DNA-konstrukter til produktion af polypeptider med højt udbytte
AU2003239863A1 (en) * 2002-05-24 2003-12-12 Restoragen Inc. Method for enzymatic production of glp-1 (7-36) amide peptides
WO2003099848A2 (en) 2002-05-24 2003-12-04 Restoragen Inc. Method for universal enzymatic production of bioactive peptides
EP1532142B1 (en) * 2002-05-24 2012-03-21 Medtronic, Inc. Polypeptide cleavage process
DK1532262T3 (da) * 2002-05-24 2013-09-16 Medtronic Inc Peptidamideringsfremgangsmåde

Also Published As

Publication number Publication date
US7829307B2 (en) 2010-11-09
EP1704234B1 (en) 2012-01-18
ATE541932T1 (de) 2012-02-15
PT1704234E (pt) 2012-04-26
RS52246B (sr) 2012-10-31
US20050164930A1 (en) 2005-07-28
ES2380765T3 (es) 2012-05-18
US20110092424A1 (en) 2011-04-21
SI1704234T1 (sl) 2012-08-31
WO2005067368A2 (en) 2005-07-28
ME01366B (me) 2013-12-20
DK1704234T3 (da) 2012-05-07
HRP20120315T1 (hr) 2012-05-31
EP1704234A2 (en) 2006-09-27
CA2546319A1 (en) 2005-07-28
EP1704234A4 (en) 2007-11-07
WO2005067368A3 (en) 2006-03-23

Similar Documents

Publication Publication Date Title
WO2007094985A3 (en) Long-acting polypeptides and methods of producing and administering same
Mentlein Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP
ES2225107T3 (es) Analogos del peptido inhibidor gastrico y su uso para el tratamiento de la diabetes.
WO2004083234A3 (en) Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
MX2021012106A (es) Factores de coagulacion de accion prolongada y metodos de produccion de los mismos.
PT1874932E (pt) Produção de proteínas recombinantes por clivagem autoproteolítica de uma proteína de fusão
MX2009002999A (es) Analogos de insulina resistentes a proteasa.
MX2010004297A (es) Antagonistas de glucagon.
WO2006126102A8 (en) Compositions and methods for fusion protein separation
WO2009155258A3 (en) Glucagon/glp-1 receptor co-agonists
PE20130326A1 (es) Analogos de glucagon
WO2008116648A3 (en) Novel glp-1 fusion peptides, their production and use
WO2007056362A3 (en) Glucagon analogs exhibiting physiological solubility and stability
CO6251278A2 (es) Metodo para la produccion de conjugados del factor de crecimiento similar a la insulina -1 y polietilenglicol
WO2008101017A3 (en) Glucagon/glp-1 receptor co-agonists
MY149128A (en) A method for the mass production of immunoglobulin fc region deleted initial methionine residues
WO2007107587A3 (en) Cholesterol lowering protein hydrolysates
PE20121033A1 (es) Produccion recombinante de peptidos
PH12012502018A1 (en) Peptide for improving biostability of bioactive substance, and bioactive substance having improved biostability
WO2007115724A3 (en) Method of increasing the in vivo recovery of therapeutic polypeptides
MY127575A (en) Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
MY148447A (en) Method for amidating polypeptides with basic aminoacid d-terminals by means of specific endoproteases
EP1704234A4 (en) PRODUCTION OF GLUCAGON-LIKE PEPTIDES 2 AND THEIR ANALOGUES
ATE548380T1 (de) Mutante des hgf-precursor-proteins und aktivierte form davon
GB0319601D0 (en) Production process